![Anti-Human/Rat Bcr Antibody [A591] - ABMIUM](http://www.abmium.com/cdn/shop/files/tlTH8P23.jpg?v=1781567393&width=520)
ElabscienceABMIUM Verified™
Anti-Human/Rat Bcr Antibody [A591]
SKU: ABM2588-1Primary Antibodies
- Target
- Bcr
- Host
- Rabbit
- Clonality
- Monoclonal
- Reactivity
- Human, Rat
- Applications
- WB, IHC
From£148.80£186.00
Save 20%
Available to orderABMIUM target intelligence
BCR activator of RhoGEF and GTPase
BCR encodes breakpoint cluster region protein, a multidomain regulator of small GTPase signalling. This ABMIUM target record connects the human BCR reference identifiers with catalogue products that target BCR.
Read full target overview
Research context & evidence
Target information is kept separate from product-level validation so you can review the biology and the reagent evidence independently.
BCR combines opposing regulatory activities toward small GTP-binding proteins. Its C-terminal GAP domain promotes GTP hydrolysis by RAC1, RAC2 and CDC42, while its central DH domain has guanine-nucleotide exchange activity toward CDC42, RHOA and RAC1. The amino terminus also has intrinsic kinase activity. BCR is additionally important because chromosomal rearrangement with ABL1 produces the BCR-ABL fusion associated with chronic myeloid leukaemia and other leukaemias.
BCR is studied in small-GTPase regulation, cytoskeletal signalling, cell motility and differentiation, and in the biology of BCR-ABL fusion-driven leukaemia. For reagent selection, distinguish assays intended for native BCR from those designed to detect a BCR-ABL fusion or a specific fusion breakpoint, and confirm species, epitope, application and product-level validation.
Names used across publications, databases and supplier catalogues.